STAND. COM. REP. NO.  1676-08

Honolulu, Hawaii

                , 2008

RE:   S.B. No. 1487

      S.D. 2

      H.D. 2

Honorable Calvin K.Y. Say

Speaker, House of Representatives

Twenty-Fourth State Legislature

Regular Session of 2008

State of Hawaii

Sir:

     Your Committee on Judiciary, to which was referred S.B. No. 1487, S.D. 2, H.D. 1, entitled:

"A BILL FOR AN ACT RELATING TO CONTROLLED SUBSTANCES,"

begs leave to report as follows:

     The purpose of the bill is to improve and update Hawaii's controlled substances law by conforming the laws to amendments made to federal law.

     Your Committee received testimony in support of the measure from the Department of Public Safety, Hawaii Pharmacists Association, Longs Drugs, and Kaiser Permanente.

     Your Committee has amended this bill by:

     (1)  Deleting the provision that repeals the exemption of certain pseudoephedrine products that are in liquid, liquid capsule, or gel capsule form from pseudoephedrine sales restrictions established under section 329-75, Hawaii Revised Statutes;

     (2)  Deleting Salvia divinorum, Salvinorin A, and Divinorin A from the list of Schedule I controlled substances;

     (3)  Deleting the provisions that repeal the existing procedures for administrative inspections and warrants and establish revised procedures;

     (4)  Changing its effective date to July 1, 2112, to encourage further discussion; and

     (5)  Making technical, nonsubstantive amendments for style, clarity, and consistency.

     As affirmed by the record of votes of the members of your Committee on Judiciary that is attached to this report, your Committee is in accord with the intent and purpose of S.B. No. 1487, S.D. 2, H.D. 1, as amended herein, and recommends that it pass Third Reading in the form attached hereto as S.B. No. 1487, S.D. 2, H.D. 2.

Respectfully submitted on behalf of the members of the Committee on Judiciary,

____________________________

TOMMY WATERS, Chair